This study is not yet accepting patients
HLA Demographics Study in Adults With Type 1 Diabetes
Summary
- Eligibility
- for people ages 18-45 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Stephen Gitelman, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Stephen Gitelman, MD
Dr. Gitelman is a physician scientist involved in studies to determine what causes type 1 diabetes mellitus (T1DM), and in clinical trials to prevent disease development, or preserve beta cell function in those recently diagnosed. To this end, he has been an active investigator in the NIH-sponsored TrialNet and Immune Tolerance Network consortia, and other immunotherapy trials in T1DM.
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- GentiBio, Inc
- ID
- NCT06860516
- Study Type
- Observational
- Participants
- Expecting 50 study participants
- Last Updated